Arash Izadpanah
About Arash Izadpanah
Arash Izadpanah is a dermatologist and the Dermatology Chairman at Scripps Clinic Medical Group in San Diego, CA, with over 20 years of experience in the field.
Current Role and Responsibilities
Arash Izadpanah is currently the Chairman of the Dermatology Division at Scripps Clinic Medical Group in San Diego, CA. He has been serving in this role since January 2019. In his capacity as Chairman, he oversees the dermatology department, guiding clinical practices and providing leadership within the division. His responsibilities include managing administrative tasks, ensuring high standards of patient care, and fostering a collaborative environment among the medical staff.
Experience in Dermatology
Arash Izadpanah has over 20 years of experience in the field of dermatology. His extensive professional career has been built on a foundation of rigorous academic training and practical clinical experience. Before assuming the chairmanship at Scripps Dermatology, he served as a dermatologist at the same institution. This long-standing tenure has equipped him with deep insights into patient care and departmental management within the field of dermatology.
Educational Background
Arash Izadpanah completed his medical education at UC San Diego, where he earned a Doctor of Medicine (MD) degree in 2002 after a five-year program. Following his MD, he pursued a Dermatology Residency Program at the same institution, completing it in 2006. This rigorous training provided him with the foundational knowledge and clinical skills necessary for his subsequent career in dermatology.
Dermatology Chairmanship at Scripps Clinic
Since January 2019, Arash Izadpanah has chaired the Dermatology Division at Scripps Clinic. In this leadership role, he has been responsible for overseeing the dermatology department's operations, enhancing patient care, and implementing best practices. His role also includes mentoring younger physicians and fostering a culture of continuous learning and improvement within the division.